Sector ratings United Therapeutics Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 14/07/2025 BST			5-day change	1st Jan Change
297.68 ^USD	+0.73%		+2.51%	-15.63%

07-14	United Therapeutics Offers Favorable Profile Ahead of Key Data, Oppenheimer Says	MT
06-30	United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG MSCI	Capi.($)
UNITED THERAPEUTICS CORPORATION	BBB	13.43B
ELI LILLY AND COMPANY	A	718B
JOHNSON & JOHNSON	A	377B
ABBVIE INC.	A	338B
NOVO NORDISK A/S	A	308B
ROCHE HOLDING AG	A	259B
NOVARTIS AG	AA	237B
ASTRAZENECA PLC	AA	222B
MERCK & CO., INC.	A	210B
AMGEN INC.	A	160B
PFIZER, INC.	BBB	144B
GILEAD SCIENCES, INC.	AAA	139B
VERTEX PHARMACEUTICALS INCORPORATED	AA	121B
SANOFI	BBB	119B
BRISTOL-MYERS SQUIBB COMPANY	A	96.34B
GSK PLC	AA	77.51B
CHUGAI PHARMACEUTICAL CO., LTD.	AA	76.79B
JIANGSU HENGRUI MEDICINE CO., LTD.	A	53.34B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	A	46.68B
Average	AA	195.68B
Weighted average by Cap.	AA